791PImpact of pembrolizumab (pembro) versus paclitaxel on health-related quality of life (HRQoL) in patients with advanced gastric or gastroesophageal junction (GEJ) cancer that has progressed after first-line chemotherapy (KEYNOTE-061)
Van Cutsem, E, Amonkar, M, Fuchs, C S, Alsina, M, Özgüroğlu, M, Bang, Y-J, Chung, H C, Muro, K, Goekkurt, E, Benson, A, Sun, W, Wainberg, Z A, Norquist, J, Chen, X, Shih, C-S, Shitara, KVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.117
Date:
October, 2019
File:
PDF, 79 KB
2019
File converter
More search results
More benefits 
